Literature DB >> 27544501

Retinal measures correlate with cognitive and physical disability in early multiple sclerosis.

Nabil K El Ayoubi1, Stephanie Ghassan1, Marianne Said1, Joelle Allam2, Hala Darwish1,3, Samia J Khoury4,5.   

Abstract

Further studies are needed to determine the role of retinal optical coherence tomography (OCT) in non-optic neuritis (ON) eyes of patients with early MS. The objective of this study is to explore the relationship between retinal layers' thickness and cognitive as well as physical disability in patients with the early RRMS. Participants in this cross-sectional study were adults with early RRMS, stable on interferon beta-1a, or fingolimod therapy, and without a history of ON in one or both eyes. Patients were evaluated clinically, underwent a battery of cognitive tests, and a retinal OCT scan which was also performed on a group of healthy age- and gender-matched controls. We studied 47 patients with RRMS, on interferon beta-1a (N = 32) or fingolimod (N = 15), and 18 healthy controls. Multivariate analyses controlling for age, disease duration, treatment, and education when exploring cognitive function, showed that pRNFL thickness correlated negatively with 9HPT (standardized Beta -0.4, p < 0.0001), and positively with SDMT (standardized Beta 0.72, p = 0.007). In patients with early RRMS without optic neuropathy, retinal thickness measures correlated with physical disability and cognitive disability, supporting their potential as biomarkers of axonal loss.

Entities:  

Keywords:  Cognitive function; Multiple sclerosis; Optical coherence tomography; Physical disability; Retinal measures

Mesh:

Year:  2016        PMID: 27544501     DOI: 10.1007/s00415-016-8271-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  Modified-Symbol Digit Modalities Test for African Americans, Caribbean Black Americans, and non-Latino Whites: nationally representative normative data from the National Survey of American Life.

Authors:  Hector M González; Keith E Whitfield; Brady T West; David R Williams; Peter A Lichtenberg; James S Jackson
Journal:  Arch Clin Neuropsychol       Date:  2007-05-09       Impact factor: 2.813

2.  Cognition in patients with multiple sclerosis After four years.

Authors:  A Jennekens-Schinkel; P M Laboyrie; J B Lanser; E A van der Velde
Journal:  J Neurol Sci       Date:  1990-11       Impact factor: 3.181

3.  Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.

Authors:  Shiv Saidha; Stephanie B Syc; Mary K Durbin; Christopher Eckstein; Jonathan D Oakley; Scott A Meyer; Amy Conger; Teresa C Frohman; Scott Newsome; John N Ratchford; Elliot M Frohman; Peter A Calabresi
Journal:  Mult Scler       Date:  2011-08-24       Impact factor: 6.312

4.  Cognitive deterioration in patients with early multiple sclerosis: a 5-year study.

Authors:  Bonnie I Glanz; Brian C Healy; Line E Hviid; Tanuja Chitnis; Howard L Weiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-07-11       Impact factor: 10.154

Review 5.  Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies.

Authors:  Jaime Imitola; Tanuja Chitnis; Samia J Khoury
Journal:  Arch Neurol       Date:  2006-01

6.  A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.

Authors:  R Zivadinov; J Sepcic; D Nasuelli; R De Masi; L M Bragadin; M A Tommasi; S Zambito-Marsala; R Moretti; A Bratina; M Ukmar; R S Pozzi-Mucelli; A Grop; G Cazzato; M Zorzon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

7.  Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy.

Authors:  Malgorzata Siger; Krzysztof Dziegielewski; Lukasz Jasek; Marek Bieniek; Agnieszka Nicpan; Jerzy Nawrocki; Krzysztof Selmaj
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

8.  Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.

Authors:  V Pueyo; J Martin; J Fernandez; C Almarcegui; J Ara; C Egea; L Pablo; F Honrubia
Journal:  Mult Scler       Date:  2008-04-18       Impact factor: 6.312

9.  Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes.

Authors:  Jeffrey M Gelfand; Douglas S Goodin; W John Boscardin; Rachel Nolan; Ami Cuneo; Ari J Green
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

10.  Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.

Authors:  Sara Llufriu; Yolanda Blanco; Eloy Martinez-Heras; Jordi Casanova-Molla; Iñigo Gabilondo; Maria Sepulveda; Carles Falcon; Joan Berenguer; Nuria Bargallo; Pablo Villoslada; Francesc Graus; Josep Valls-Sole; Albert Saiz
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

View more
  10 in total

Review 1.  Cognitive Assessment of Individuals with Multiple Sclerosis in the Arab World: a Systematic Review.

Authors:  Samira Paul; Aeysha Brown; Abbey J Hughes
Journal:  Neuropsychol Rev       Date:  2019-05-17       Impact factor: 7.444

Review 2.  What Does Optical Coherence Tomography Offer for Evaluating Physical Disability in Patients with Multiple Sclerosis?

Authors:  Ziya Ayhan; Aylin Yaman
Journal:  Noro Psikiyatr Ars       Date:  2018       Impact factor: 1.339

Review 3.  Monitoring the Course of MS With Optical Coherence Tomography.

Authors:  Alexander U Brandt; Elena H Martinez-Lapiscina; Rachel Nolan; Shiv Saidha
Journal:  Curr Treat Options Neurol       Date:  2017-04       Impact factor: 3.598

4.  Relation between retina, cognition and brain volumes in MS: a consequence of asymptomatic optic nerve lesions.

Authors:  Jean-Baptiste Davion; Caroline Jougleux; Renaud Lopes; Xavier Leclerc; Olivier Outteryck
Journal:  J Neurol       Date:  2022-08-26       Impact factor: 6.682

Review 5.  Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies.

Authors:  Rachel C Nolan; Omar Akhand; John-Ross Rizzo; Steven L Galetta; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2018-06       Impact factor: 3.042

6.  Visual Pathway Measures are Associated with Neuropsychological Function in Multiple Sclerosis.

Authors:  James Nguyen; Alissa Rothman; Kathryn Fitzgerald; Anna Whetstone; Stephanie Syc-Mazurek; Jannelle Aquino; Laura J Balcer; Elliot M Frohman; Teresa C Frohman; Ciprian Crainiceanu; Meghan Beier; Scott D Newsome; Peter A Calabresi; Shiv Saidha
Journal:  Curr Eye Res       Date:  2018-05-01       Impact factor: 2.424

7.  Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis.

Authors:  Noha Abo Koraysha; Nirmeen Kishk; Amr Hassan; Nehal M Samy El Gendy; Hatem S Shehata; Salsabil Abo Al-Azayem; Yasmine Shawki Kamal
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-06       Impact factor: 2.570

Review 8.  Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important?

Authors:  Magdalena Oset; Mariusz Stasiolek; Mariola Matysiak
Journal:  Curr Neurol Neurosci Rep       Date:  2020-05-22       Impact factor: 5.081

9.  Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.

Authors:  Rachel C Nolan; Steven L Galetta; Teresa C Frohman; Elliot M Frohman; Peter A Calabresi; Carmen Castrillo-Viguera; Diego Cadavid; Laura J Balcer
Journal:  J Neuroophthalmol       Date:  2018-12       Impact factor: 3.042

10.  Association of Retinal Layer Thickness With Cognition in Patients With Multiple Sclerosis.

Authors:  Sharon Jean Baetge; Michael Dietrich; Melanie Filser; Alina Renner; Nathalie Stute; Marcia Gasis; Margit Weise; Klaudia Lepka; Jonas Graf; Norbert Goebels; Hans-Peter Hartung; Orhan Aktas; Sven Meuth; Philipp Albrecht; Iris-Katharina Penner
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-05-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.